BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25104797)

  • 1. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
    Padilla N; Maraninchi M; Béliard S; Berthet B; Nogueira JP; Wolff E; Nicolay A; Bégu A; Dubois N; Grangeot R; Mattei C; Vialettes B; Xiao C; Lewis GF; Valéro R
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
    Dash S; Xiao C; Morgantini C; Szeto L; Lewis GF
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2895-901. PubMed ID: 24072699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.
    Nogueira JP; Maraninchi M; Béliard S; Padilla N; Duvillard L; Mancini J; Nicolay A; Xiao C; Vialettes B; Lewis GF; Valéro R
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1039-44. PubMed ID: 22308041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
    Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
    Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
    Maraninchi M; Padilla N; Béliard S; Berthet B; Nogueira JP; Dupont-Roussel J; Mancini J; Bégu-Le Corroller A; Dubois N; Grangeot R; Mattei C; Monclar M; Calabrese A; Guérin C; Desmarchelier C; Nicolay A; Xiao C; Borel P; Lewis GF; Valéro R
    J Clin Lipidol; 2017; 11(2):495-506.e3. PubMed ID: 28502507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism.
    Dash S; Xiao C; Lewis GF
    Curr Opin Lipidol; 2016 Feb; 27(1):14-8. PubMed ID: 26628436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production.
    Duez H; Lamarche B; Uffelman KD; Valéro R; Szeto L; Lemieux S; Cohn JS; Lewis GF
    J Clin Endocrinol Metab; 2008 May; 93(5):1722-9. PubMed ID: 18285418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.
    Chan DC; Watts GF; Somaratne R; Wasserman SM; Scott R; Barrett PHR
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1644-1655. PubMed ID: 29880491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of growth hormone in hepatic and intestinal triglyceride-rich lipoprotein metabolism.
    Maraninchi M; Calabrese A; Nogueira JP; Castinetti F; Mancini J; Mourre F; Piétri L; Bénamo E; Albarel F; Morange I; Dupont-Roussel J; Nicolay A; Brue T; Béliard S; Valéro R
    J Clin Lipidol; 2021; 15(5):712-723. PubMed ID: 34462238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study.
    Borén J; Watts GF; Adiels M; Söderlund S; Chan DC; Hakkarainen A; Lundbom N; Matikainen N; Kahri J; Vergès B; Barrett PH; Taskinen MR
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2218-24. PubMed ID: 26315407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men.
    Xiao C; Dash S; Stahel P; Lewis GF
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1776-1781. PubMed ID: 28751575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women.
    Mekki N; Christofilis MA; Charbonnier M; Atlan-Gepner C; Defoort C; Juhel C; Borel P; Portugal H; Pauli AM; Vialettes B; Lairon D
    J Clin Endocrinol Metab; 1999 Jan; 84(1):184-91. PubMed ID: 9920081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial lipemia associates with liver fat content.
    Matikainen N; Mänttäri S; Westerbacka J; Vehkavaara S; Lundbom N; Yki-Järvinen H; Taskinen MR
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3052-9. PubMed ID: 17488790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
    Hooper AJ; Robertson K; Barrett PH; Parhofer KG; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1474-8. PubMed ID: 17213276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Glucose Acutely Stimulates Intestinal Lipoprotein Secretion in Healthy Humans.
    Xiao C; Dash S; Morgantini C; Lewis GF
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1457-63. PubMed ID: 27150393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-2 regulates release of chylomicrons from the intestine.
    Dash S; Xiao C; Morgantini C; Connelly PW; Patterson BW; Lewis GF
    Gastroenterology; 2014 Dec; 147(6):1275-1284.e4. PubMed ID: 25173752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.
    Duez H; Lamarche B; Uffelman KD; Valero R; Cohn JS; Lewis GF
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1357-63. PubMed ID: 16614317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.